Technology relates to a chemoenzymatic process for Stereoselective preparation of (R)-GABOB and Carnitine comprising tosylating 3,4-dihydroxybutanenitrile, resoluting racemic 3-hydroxy-4-tosyloxybutanenitrile and coverting the racemate to (R)-GABOB and Carnitine.

Patent Application Number:7816119

For more details about technology: Click here

Invention relates to a process for preparing chromium dioxide and other oxides of chromium. Hard sintered chromium oxide can be obtained without introducing any detectable impurity phase and the obtained chromium oxides and composites have shown significant negative magnetoresistance near room temperature. Chromium oxides have application in magnetic recording application.

Patent Application Number: 7276226

For more details about technology: Click here

Technology relates to a chemo enzymatic process for the stereo selective preparation of both enantiomers of 3-hydroxy-4-trityloxy butanenitrile and their effective application in the preparation of (R)-GABOB through an enantioconvergent process comprising transesterifying 3-hydroxy-4-trityloxybutanenitrile, transforming optically pure 3-acetyloxy-4-trityloxybutanenitrile to (R)-GABOB and transforming 3-hydroxy-4-trityloxybutanenitrile to (R)-GABOB.

Patent Application Number: 7374926 , Granted EP, Indian and JP patent.

For more details about technology: Click here

Invention relates to methods of coating the surface of prosthetic devices with fibrin and drying the fibrin-coated prosthetic devices at moderately-high temperatures for extended periods of time under low atmospheric pressure to obtain prosthetic devices coated with stable cross-linked fibrin capable of binding cells and thereby capable of integrating into tissues.

Patent Application Number: WO2010/131249

For more details about technology: Click here

Invention relates to a impurity free preparation process of 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-y-oxo-n-beta-diphenylbenzenebutanamide, a key intermediate for the synthesis of Atorvastatin. Atorvastatin a drug useful for lowering blood cholesterol, stabilizing plaque and preventing stroke through anti-inflamatory and other mechanisms.

For more details about technology: Click here

Invention relates to a drug delivery device which is portable, easy to use iontophoretic device that ejects a high content of drug from a soft gel upon application of a low current. The device is intended to safely apply large amounts of drug to the posterior ocular tissues and to replace the use of recurrent intravitreal injections, therefore preventing the pain and complications that patients are forced to deal with today.
Patent Application Number: WO2005/084748

For more details about technology: Click here